Abstract
An improved and scaleable process for Dutasteride (1), a synthetic 4-azasteroid derivative essentially used for the treatment of prostate diseases, is described.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have